Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
2.050
-0.110 (-5.09%)
At close: Dec 20, 2024, 4:00 PM
2.040
-0.010 (-0.49%)
After-hours: Dec 20, 2024, 5:12 PM EST
Innate Pharma Employees
Innate Pharma had 179 employees as of December 31, 2023. The number of employees decreased by 32 or -15.17% compared to the previous year.
Employees
179
Change (1Y)
-32
Growth (1Y)
-15.17%
Revenue / Employee
$202,250
Profits / Employee
-$203,830
Market Cap
162.24M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Lyell Immunopharma | 224 |
TScan Therapeutics | 154 |
Nkarta | 150 |
Nektar Therapeutics | 137 |
BrainsWay | 134 |
Kyverna Therapeutics | 96 |
Solid Biosciences | 88 |
Elutia | 54 |
IPHA News
- 1 day ago - Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 12 days ago - Innate Pharma Presents Lacutamab Improved Health-related Quality of Life Data at ASH 2024 From TELLOMAK Phase 2 Study in Patients With Cutaneous T Cell Lymphoma - Business Wire
- 15 days ago - Innate Pharma and the Institute for Follicular Lymphoma Innovation (IFLI) Announce up to $7.9M Investment From IFLI to Support IPH6501 Development in Follicular Lymphoma - Business Wire
- 18 days ago - Innate Pharma Highlights Abstracts Selected for the ASH Annual Meeting 2024 - Business Wire
- 26 days ago - Innate Pharma: Looking Like A Company We'll Regret Ignoring - Seeking Alpha
- 4 weeks ago - Innate Pharma Releases Its 2025 Financial Calendar - Business Wire
- 4 weeks ago - Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET® IPH6501 - Business Wire
- 5 weeks ago - Innate Pharma S.A. (IPHA) Q3 2024 Earnings Call Transcript - Seeking Alpha